Many organizations have struggled to find a balance between effectiveness and efficiency in this regard, as the “correct strategy” is subjective.
TORONTO (PRWEB) January 13, 2020
As the use of eClinical technology grows, regulatory agencies are increasing their expectations of trial sponsors to demonstrate oversight and active management of their Interactive Response Technology (IRT). Many organizations have struggled to find a balance between effectiveness and efficiency in this regard, as the “correct strategy” is subjective.
Join featured speakers from Almac Clinical Technologies - Bob Weney, Director of Technical Solutions and Matt Lowrie, QA Manager, ASQ CQA, Quality Assurance for an informative live session on Thursday, January 30, 2020 at 11am EST (4pm GMT/UK).
The presentation will appeal to individuals working in pharma, biotech and Contract Research Organizations (CROs) with the following or related job titles:
- Study Leads/Managers
- Vendor Managers
- IRT Experts
- Medication/Supply Managers
- Systems Validation personnel
For more information or to register for this event, visit Sponsor Oversight Responsibilities for IRT: Proactive Management that Meets Regulatory Scrutiny.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.